The concept of synthetic lethality-based interventions is particularly interesting for inherited RCC (and haemangioblastomas) in disorders such as VHL disease, because the kidneys of VHL patients can harbour hundreds of small “tumourlets” with biallelic VHL inactivation, some of which will give rise to RCC years later [50]. The gene discussed is VHL; the disease is renal cell carcinoma.